Concert Pharmaceuticals to Report First Quarter 2019 Financial Results on May 2, 2019
25 Abril 2019 - 6:00AM
Business Wire
Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced
that it will report its first quarter 2019 financial results on
Thursday, May 2, 2019, before the U.S. financial markets open. The
Company will host a conference call and webcast at 8:30 a.m. ET to
discuss first quarter financial results and provide a business
update. Individuals interested in participating in the call should
dial (855) 354-1855 (U.S. and Canada) or (484) 365-2865
(International).
A live webcast of the first quarter financial results may be
accessed in the Investors section of the Company’s website at
www.concertpharma.com. Please log on to the Concert website
approximately 15 minutes prior to the scheduled webcast to ensure
adequate time for any software downloads that may be required. A
replay of the first quarter financial results webcast will be
available on Concert’s website for three months.
About ConcertConcert Pharmaceuticals is a clinical stage
biopharmaceutical company focused on applying its DCE Platform®
(deuterated chemical entity platform) to create novel medicines
designed to treat serious diseases and address unmet patient needs.
The Company’s approach starts with previously studied compounds,
including approved drugs, in which deuterium substitution has the
potential to enhance clinical safety, tolerability or efficacy.
Concert’s pipeline of innovative medicines targets
autoimmune diseases and central nervous systems (CNS) disorders.
For more information please visit www.concertpharma.com or follow
us on Twitter at @ConcertPharma or on LinkedIn.
Concert Pharmaceuticals Inc., the CoNCERT
Pharmaceuticals Inc. logo and DCE Platform are registered
trademarks of Concert Pharmaceuticals, Inc.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190425005082/en/
Justine Koenigsberg(781) 674-5284ir@concertpharma.com
Concert Pharmaceuticals (NASDAQ:CNCE)
Gráfica de Acción Histórica
De Jun 2024 a Jul 2024
Concert Pharmaceuticals (NASDAQ:CNCE)
Gráfica de Acción Histórica
De Jul 2023 a Jul 2024
Real-Time news about Concert Pharmaceuticals Inc (NASDAQ): 0 recent articles
Más de Concert Pharmaceuticals, Inc. Artículos de Noticias